Related Experiment Video
Updated: Feb 24, 2026

09:37
Imine Metathesis by Silica-Supported Catalysts Using the Methodology of Surface Organometallic Chemistry
Published on: October 18, 2019
10.2K
Stabilizing Unstable Amorphous Menthol through Inclusion in Mesoporous Silica Hosts
Teresa Cordeiro1, Carmem Castiñeira2, Davide Mendes1
1LAQV-REQUIMTE/CQFB, Departamento de Química, Faculdade de Ciências e Tecnologia, Universidade Nova de Lisboa , 2829-516 Caparica, Portugal.
Molecular Pharmaceutics
|August 25, 2017
Summary
Amorphizing menthol within mesoporous silica matrices prevents crystallization, enabling controlled drug release. Pore size tuning influences menthol mobility and release rates, highlighting potential for advanced drug delivery systems.
Area of Science:
- Materials Science
- Physical Chemistry
- Pharmaceutical Sciences
Background:
- Menthol, a crystallizable therapeutic and food additive, often requires stabilization for effective drug delivery.
- Mesoporous silica matrices offer a promising platform for stabilizing amorphous forms of active pharmaceutical ingredients.
Purpose of the Study:
- To investigate the amorphization of neat menthol within mesoporous silica matrices of varying pore sizes (3.2 and 5.9 nm).
- To characterize the physical state and molecular mobility of menthol within these matrices.
- To evaluate the potential of these composites as drug delivery systems with tunable release profiles.
Main Methods:
- Loading neat menthol into mesoporous silica with 3.2 nm and 5.9 nm pores.
- Differential Scanning Calorimetry (DSC) to detect glass transitions and confirm amorphization.
- Dielectric Relaxation Spectroscopy (DRS) to probe menthol molecular mobility and identify relaxation processes (α and S-processes).
Main Results:
- Successful amorphization of menthol was achieved in both pore sizes, evidenced by calorimetric glass transitions (Tg = -54.3 °C).
- Nonisothermal crystallization was suppressed, indicating a stable amorphous/supercooled state within the silica pores.
- DRS revealed two relaxation processes: a faster α-process (neat-like menthol) and a slower, dominant S-process (adsorbed menthol).
- The 5.9 nm pore size showed a greater fraction of mobile α-process molecules, leading to faster initial drug release.
- The 3.2 nm pore size inhibited crystallization due to pore dimensions smaller than menthol's critical nucleation size.
Conclusions:
- Mesoporous silica matrices effectively stabilize amorphous menthol, preventing crystallization.
- Tuning the host pore size allows control over menthol mobility and consequently, drug release kinetics.
- These menthol-silica composites show significant potential as tunable drug delivery systems.
Keywords:
THEDESamorphous statedrug releaseflurbiprofenmentholmesoporous silica matrixesmolecular mobility
